InsiderClue
← All stocks

CVRx, Inc.

CVRX Net buying
CIK 0001235912 #4489 in the set updated 18 Sep 2026
Bought (120 mo)
$26.47M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.02M
$129.91K on a plan · $245.87K straight out of an exercise
Sold at will
$648.65K
7 of 19 sales
Net
+$25.44M
+$25.82M against sales at will

By person

27 insiders · 134 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GSK plc entity
10% owner
$4.95M (1)
—
+$4.95M
1,007,583
3.78%
$2.94M
+3,067%
Pardo Geoffrey B
Director
$4.95M (1)
—
+$4.95M
1,829,022
6.87%
$5.33M
—
NEA PARTNERS 10 L P entity
10% owner
$4.50M (2)
—
+$4.50M
2,199,471
8.26%
$6.41M
+158,821%
Jain Mudit K.
Director
$4.37M (10)
—
+$4.37M
1,927,936
7.24%
$5.62M
+106.6%
NEW ENTERPRISE ASSOCIATES 10 L P entity
10% owner
$4.06M (1)
—
+$4.06M
2,026,083
7.60%
$5.91M
—
Nielsen Kirk G.
Director
$2.71M (17)
—
+$2.71M
3,380,685
12.69%
$9.85M
+131.3%
JOHNSON & JOHNSON
10% owner
—
$733.14K (7)
−$733.14K
7,536,436
28.29%
$21.97M
+115.6%
NEHRA JOHN M
Director
$502.65K (3)
—
+$502.65K
28,366
0.1065%
$82.68K
+5,701%
Hykes Kevin
PRES & CEO
$274.97K (2)
$61.35K (1) scheduled
+$213.62K
284,237
1.07%
$828.47K
—
VERRASTRO PAUL
CHIEF MKTG & STRAT OFFICER
—
$171.52K (7) scheduled
−$171.52K
60,551
0.2273%
$176.49K
—
Binkowski Brent
CHIEF OPERATING OFFICER
$76.43K (1)
$3.34K (1) scheduled
+$73.09K
56,514
0.2121%
$164.72K
—
SLATTERY JOSEPH P
Director
$71.74K (3)
—
+$71.74K
39,365
0.1478%
$114.74K
—
John Robert Allen
Chief Revenue Officer
—
$31.33K (1) scheduled
−$31.33K
86,036
0.3229%
$250.77K
—
OASHEIM JARED
CHIEF FINANCIAL OFFICER
—
$13.78K (1) scheduled
−$13.78K
96,703
0.3630%
$281.86K
—
Adamson Philip B.
Chief Medical Officer
—
$9.97K (1) scheduled
−$9.97K
61,578
0.2311%
$179.48K
+3,247%
BRUHN-DING DEAN
VP OF REG. AFFAIRS AND QA
—
—
—
54,648
0.2051%
$159.28K
+867.6%
Morrison Gregory
CHIEF HUMAN RESOURCES OFFICER
—
—
—
34,000
0.1276%
$99.10K
—
BRINTNALL JOHN
CHIEF STRATEGY OFFICER AND SEC
—
—
—
31,527
0.1183%
$91.89K
+227.5%
DALE MICHAEL D
Director
—
—
—
29,005
0.1089%
$84.54K
—
Yared Nadim
CHIEF EXECUTIVE OFFICER
—
—
—
26,255
0.0985%
$76.53K
—
SHADAN MARTHA
Director
—
—
—
8,720
0.0327%
$25.42K
—
Hill, Mitch C.
Director
—
—
—
8,720
0.0327%
$25.42K
—
Ballinger Kevin J.
Director
—
—
—
8,720
0.0327%
$25.42K
—
Palmer Craig E.
SVP, U.S. SALES
—
—
—
1,229
0.0046%
$3.58K
—
Galle Liz
VP OF GLOBAL CLINICAL RESEARCH
—
—
—
778
0.0029%
$2.27K
—
Behbahani Ali
Director
—
—
—
316
0.0012%
$921.05
—
Johnson & Johnson Innovation - JJDC, Inc. entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

41
Insider
Date
Role
Action
Shares
Price
Amount
Binkowski Brent
13 Aug 2026
CHIEF OPERATING OFFICER
Buy
26,223
$2.91
$76.43K
Jain Mudit K.
20 Feb 2026
Director
Buy indirect
46,800
$6.36
$297.59K
Jain Mudit K.
18 Feb 2026
Director
Buy
600
$4.64
$2.79K
Nielsen Kirk G.
15 May 2025
Director
Buy indirect
10,966
$5.45
$59.80K
Nielsen Kirk G.
14 May 2025
Director
Buy indirect
61,200
$5.23
$320.36K
Jain Mudit K.
13 May 2025
Director
Buy
150
$5.26
$789.00
Nielsen Kirk G.
13 May 2025
Director
Buy indirect
101,413
$5.29
$536.31K
Hykes Kevin
12 May 2025
PRES & CEO
Buy
5,000
$4.84
$24.20K
Jain Mudit K.
12 May 2025
Director
Buy
1,500
$4.66
$6.99K
Nielsen Kirk G.
12 May 2025
Director
Buy indirect
25,200
$4.79
$120.67K
SLATTERY JOSEPH P
15 Aug 2024
Director
Buy
3,000
$8.10
$24.30K
SLATTERY JOSEPH P
8 Aug 2024
Director
Buy
3,000
$8.24
$24.72K
SLATTERY JOSEPH P
6 Aug 2024
Director
Buy
2,500
$9.09
$22.73K
Hykes Kevin
5 Aug 2024
PRES & CEO
Buy
30,000
$8.36
$250.77K
Nielsen Kirk G.
24 May 2022
Director
Buy indirect
8,070
$5.05
$40.75K
Nielsen Kirk G.
23 May 2022
Director
Buy indirect
4,432
$5.04
$22.34K
Nielsen Kirk G.
20 May 2022
Director
Buy indirect
13,387
$5.04
$67.41K
Nielsen Kirk G.
19 May 2022
Director
Buy indirect
10,976
$5.04
$55.30K
Nielsen Kirk G.
5 May 2022
Director
Buy indirect
3,992
$6.00
$23.94K
Nielsen Kirk G.
4 May 2022
Director
Buy indirect
25,503
$5.99
$152.76K
Nielsen Kirk G.
3 May 2022
Director
Buy indirect
32,809
$6.00
$196.76K
Nielsen Kirk G.
2 May 2022
Director
Buy indirect
41,988
$5.97
$250.67K
Nielsen Kirk G.
28 Apr 2022
Director
Buy indirect
100
$5.97
$597.00
Jain Mudit K.
28 Feb 2022
Director
Buy
600
$9.03
$5.42K
Nielsen Kirk G.
24 Feb 2022
Director
Buy indirect
3,400
$8.24
$28.01K
Nielsen Kirk G.
23 Feb 2022
Director
Buy indirect
38,200
$8.04
$307.14K
Nielsen Kirk G.
22 Feb 2022
Director
Buy indirect
40,008
$7.94
$317.66K
Nielsen Kirk G.
18 Feb 2022
Director
Buy indirect
26,659
$7.92
$211.23K
Jain Mudit K.
19 Nov 2021
Director
Buy
300
$13.69
$4.11K
Jain Mudit K.
18 Nov 2021
Director
Buy
875
$14.63
$12.80K
Jain Mudit K.
12 Aug 2021
Director
Buy
625
$19.72
$12.33K
Pardo Geoffrey B
2 Jul 2021
Director
Buy indirect
275,000
$18.00
$4.95M
Jain Mudit K.
2 Jul 2021
Director
Buy indirect
222,222
$18.00
$4.00M
NEHRA JOHN M
2 Jul 2021
Director
Buy
27,777
$18.00
$499.99K
GSK plc
2 Jul 2021
10% owner
Buy indirect
275,000
$18.00
$4.95M
NEW ENTERPRISE ASSOCIATES 10 L P
2 Jul 2021
10% owner
Buy
225,500
$18.00
$4.06M
NEA PARTNERS 10 L P
2 Jul 2021
10% owner
Buy indirect
24,750
$18.00
$445.50K
NEA PARTNERS 10 L P
2 Jul 2021
10% owner
Buy indirect
225,500
$18.00
$4.06M
Jain Mudit K.
1 Jul 2021
Director
Buy
1,000
$25.10
$25.10K
NEHRA JOHN M
1 Jul 2021
Director
Buy indirect
50
$25.80
$1.29K
NEHRA JOHN M
30 Jun 2021
Director
Buy indirect
50
$27.43
$1.37K
Show all 134 transactions →

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 6
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 16,679,432
History held since 1 Jul 2021